00

studies recruiting now

checking live

00

studies registered in total

checking live

00

countries with a recruiting site

checking live

00

recruiting study posted to date

checking live

Recruiting trials

Fetching live from ClinicalTrials.gov. This condition is not yet in our weekly snapshot; live results only.

Keep watching

Get an email when a new Lymphoma study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

A group of conditions, not a single diagnosis

Orphanet classifies “Lymphoma” as a category that groups several related conditions. Trials are usually registered under the specific condition, so the figures above may undercount. Browse the conditions in this group or see the classification on Orphanet.

Treatments being studied

21 approved treatments and 332 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Prednisone (Cortan)Approved: Methylprednisolone Acetate (Depo-medrol)Approved: Rasburicase (Elitek)Approved: Vinblastine Sulfate (Velban)Approved: Dexamethasone (Aeroseb-dex)Approved: Methylprednisolone Sodium Succinate (A-methapred)Approved: Lorlatinib (Lorbrena)Approved: Cortisone Acetate (Cortate)Approved: Dexamethasone Sodium Phosphate (Ak-dex)Approved: Cyclophosphamide (Cyclophosphamide)Approved: Tagraxofusp (Elzonris)Approved: Crisantaspase (Enrylaze)Approved: Tafasitamab (Minjuvi)Approved: Prednisolone (Cortalone)Approved: Plerixafor (Mozobil)Approved: Glembatumumab VedotinApproved: Pegaspargase (Oncaspar)Approved: Duvelisib Monohydrate (Copiktra)Approved: Allopurinol (Allopurinol)Approved: Bleomycin Sulfate (Blenoxane)Approved: Hydrocortisone (Acetasol hc)
Phase 3Pralatrexate (Folotyn)
Phase 3Epoetin Beta (Neorecormon)
Phase 3Carmustine (Bicnu)
Phase 3Romidepsin (Chromadax)
Phase 3Mechlorethamine Hydrochloride (Mustargen)
Phase 3Enalapril
Phase 3Methotrexate (Ebetrex)
Phase 3Epratuzumab

+ 324 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).